November 8, 2016 / 12:42 PM / a year ago

BRIEF-Promis Neurosciences initiates cohort study for alzheimer's disease

Nov 8 (Reuters) - Promis Neurosciences Inc

* Promis neurosciences initiates cohort study to evaluate prevalence of different amyloid beta prion strains in alzheimer’s disease

* Promis neurosciences inc - first results of cohort study are anticipated in q1 2017. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below